{"id":4578,"date":"2020-03-13T08:54:34","date_gmt":"2020-03-13T07:54:34","guid":{"rendered":"https:\/\/www.toulouse-white-biotechnology.com\/insights\/actualites\/actualite\/three-new-partners-2\/"},"modified":"2026-03-16T14:27:44","modified_gmt":"2026-03-16T13:27:44","slug":"three-new-partners-2","status":"publish","type":"post","link":"https:\/\/www.toulouse-white-biotechnology.com\/en\/insights\/blog\/three-new-partners-2\/","title":{"rendered":"Three new partners"},"content":{"rendered":"\n

The TWB consortium has welcomed 3 new partners on January 2020 : Elaia, N\u00e9omerys and Sensient.<\/p>\n

\u00a0<\/p>\n

\"\"<\/a>Sensient Cosmetic Technologies<\/a> <\/strong>produces and markets high-performance solutions in the following technologies: dyes, flavours and fragrances. Sensient is committed to the development of natural products in these areas.

<\/p>\n

\"\"<\/a>N\u00e9omerys<\/a><\/strong> is an applied research start-up that develops new applications based on microalgae (eco-positive biofuels, pharmacological diagnostic tools, environmental technologies).

<\/p>\n

\"\"<\/a><\/p>\n


Elaia<\/a> <\/strong>is a venture capital fund investing in particular in high-potential digital and deeptech start-ups (including Life Sciences). In this context, Elaia works a lot with the research world.<\/p>\n



The consortium<\/a> is now composed of 52 private and public partners <\/strong>(8 large companies, 2 mid-cap company, 7 small and medium companies, 19 very small companies, 5 investors, 3 valorisation structures, 9 public partners). The companies operate in different fields: Agro-industry \/ Chemicals (materials and products) \/ Equipment \/ Biotechnology solutions \/ Flavors and Cosmetics \/ Energy and Pharmacy.<\/p>\n

\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":4705,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_schema_org_content_json":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-4578","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/posts\/4578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/comments?post=4578"}],"version-history":[{"count":1,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/posts\/4578\/revisions"}],"predecessor-version":[{"id":4702,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/posts\/4578\/revisions\/4702"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/media\/4705"}],"wp:attachment":[{"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/media?parent=4578"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/categories?post=4578"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.toulouse-white-biotechnology.com\/en\/wp-json\/wp\/v2\/tags?post=4578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}